COVID-19合并蓝色炎性疼痛性水肿一例:筋膜切开与机械取栓有效治疗
本文报告一名53岁男性重症SARS-CoV2肺炎患者,发生急性髂股深静脉血栓导致蓝色炎性疼痛性水肿及急性肢体缺血,成功接受急诊筋膜切开和机械取栓,清除大量血栓并恢复静脉循环,提示对SARS-CoV2相关静脉血栓栓塞需临床警惕和早期干预。
要点
- COVID-19增加静脉血栓栓塞风险,包括深静脉血栓和肺栓塞。
- 蓝色炎性疼痛性水肿是深静脉血栓罕见极端表现,可致肢体和生命危险的静脉性坏疽。
- 对SARS-CoV2相关静脉血栓栓塞并发症应早期识别并实施治疗干预。
核心结论
- 对COVID-19患者发生的SARS-CoV2相关静脉血栓栓塞并发症,临床警惕和早期治疗干预可避免不良结局。
研究设计与样本
- 个案报告:一名53岁男性重症SARS-CoV2肺炎患者。
主要发现
- 患者发生急性髂股深静脉血栓,导致蓝色炎性疼痛性水肿及急性肢体缺血。
- 患者接受急诊筋膜切开和机械取栓,清除大量血栓并恢复正常静脉循环。
临床怎么用
- 对COVID-19患者应临床警惕静脉血栓栓塞,早期识别并实施治疗干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronavirus disease 2019 (COVID-19) has been widely reported to be associated with increased risk of Venous Thromboembolism, both deep vein thrombosis (DVT) and pulmonary embolism. A rare and extreme manifestation of DVT is Phlegmasia cerulea dolens, characterized by poor tissue perfusion due to marked limb swelling which can progress to limb and life-threatening venous gangrene. We report the case of a 53-year-old man with severe SARS-CoV2 pneumonia who developed acute iliofemoral DVT leading to acute limb ischemia due to Phlegmasia cerulea dolens. The patient underwent successful emergent fasciotomy and mechanical thrombectomy with removal of extensive thrombus burden and restoration of normal venous circulation. Our case highlights the importance of clinical vigilance and early implementation of therapeutic interventions to avoid adverse outcomes in patients who develop SARS-CoV2 induced Venous Thromboembolism complications.
引用
- Gutierrez JR, Volteas P, Skripochnik E, et al. A Case of Phlegmasia Cerulea Dolens in a Patient With COVID-19, Effectively Ttreated With Fasciotomy and Mechanical Thrombectomy. Ann Vasc Surg. 2021. PMID: 34644637. doi:10.1016/j.avsg.2021.07.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。